Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil

Omecamtiv mecarbil (OM) is a cardiac myosin activator that is currently in clinical trials for heart failure treatment. Here, the authors give insights into its mode of action and present the crystal structure of OM bound to bovine cardiac myosin, which shows that OM stabilizes the pre-powerstroke s...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vicente J. Planelles-Herrero, James J. Hartman, Julien Robert-Paganin, Fady I. Malik, Anne Houdusse
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Q
Acceso en línea:https://doaj.org/article/e89f50badcf146dca49a24d78e0e1fa7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e89f50badcf146dca49a24d78e0e1fa7
record_format dspace
spelling oai:doaj.org-article:e89f50badcf146dca49a24d78e0e1fa72021-12-02T13:27:22ZMechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil10.1038/s41467-017-00176-52041-1723https://doaj.org/article/e89f50badcf146dca49a24d78e0e1fa72017-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-017-00176-5https://doaj.org/toc/2041-1723Omecamtiv mecarbil (OM) is a cardiac myosin activator that is currently in clinical trials for heart failure treatment. Here, the authors give insights into its mode of action and present the crystal structure of OM bound to bovine cardiac myosin, which shows that OM stabilizes the pre-powerstroke state of myosin.Vicente J. Planelles-HerreroJames J. HartmanJulien Robert-PaganinFady I. MalikAnne HoudusseNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-10 (2017)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Vicente J. Planelles-Herrero
James J. Hartman
Julien Robert-Paganin
Fady I. Malik
Anne Houdusse
Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil
description Omecamtiv mecarbil (OM) is a cardiac myosin activator that is currently in clinical trials for heart failure treatment. Here, the authors give insights into its mode of action and present the crystal structure of OM bound to bovine cardiac myosin, which shows that OM stabilizes the pre-powerstroke state of myosin.
format article
author Vicente J. Planelles-Herrero
James J. Hartman
Julien Robert-Paganin
Fady I. Malik
Anne Houdusse
author_facet Vicente J. Planelles-Herrero
James J. Hartman
Julien Robert-Paganin
Fady I. Malik
Anne Houdusse
author_sort Vicente J. Planelles-Herrero
title Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil
title_short Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil
title_full Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil
title_fullStr Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil
title_full_unstemmed Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil
title_sort mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/e89f50badcf146dca49a24d78e0e1fa7
work_keys_str_mv AT vicentejplanellesherrero mechanisticandstructuralbasisforactivationofcardiacmyosinforceproductionbyomecamtivmecarbil
AT jamesjhartman mechanisticandstructuralbasisforactivationofcardiacmyosinforceproductionbyomecamtivmecarbil
AT julienrobertpaganin mechanisticandstructuralbasisforactivationofcardiacmyosinforceproductionbyomecamtivmecarbil
AT fadyimalik mechanisticandstructuralbasisforactivationofcardiacmyosinforceproductionbyomecamtivmecarbil
AT annehoudusse mechanisticandstructuralbasisforactivationofcardiacmyosinforceproductionbyomecamtivmecarbil
_version_ 1718393007289401344